Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness : Mechanisms and Future Outlook
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
The creation of mRNA vaccines has transformed the area of vaccination and allowed for the production of COVID-19 vaccines with previously unheard-of speed and effectiveness. The development of novel strategies to enhance the delivery and efficiency of mRNA vaccines has been motivated by the ongoing constraints of the present mRNA vaccine delivery systems. In this context, intriguing methods to get beyond these restrictions include lipid nanoparticles, self-amplifying RNA, electroporation, microneedles, and cell-targeted administration. These innovative methods could increase the effectiveness, safety, and use of mRNA vaccines, making them more efficient, effective, and broadly available. Additionally, mRNA technology may have numerous and far-reaching uses in the field of medicine, opening up fresh avenues for the diagnosis and treatment of disease. This paper gives an overview of the existing drawbacks of mRNA vaccine delivery techniques, the creative solutions created to address these drawbacks, and their prospective public health implications. The development of mRNA vaccines for illnesses other than infectious diseases and creating scalable and affordable manufacturing processes are some of the future directions for research in this area that are covered in this paper.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Current pharmaceutical design - (2024) vom: 28. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Verma, Abhishek [VerfasserIn] |
---|
Links: |
---|
Themen: |
Electroporation |
---|
Anmerkungen: |
Date Revised 29.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.2174/0113816128296588240321072042 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370405838 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM370405838 | ||
003 | DE-627 | ||
005 | 20240330003125.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240330s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/0113816128296588240321072042 |2 doi | |
028 | 5 | 2 | |a pubmed24n1355.xml |
035 | |a (DE-627)NLM370405838 | ||
035 | |a (NLM)38551046 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Verma, Abhishek |e verfasserin |4 aut | |
245 | 1 | 0 | |a Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness |b Mechanisms and Future Outlook |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 29.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a The creation of mRNA vaccines has transformed the area of vaccination and allowed for the production of COVID-19 vaccines with previously unheard-of speed and effectiveness. The development of novel strategies to enhance the delivery and efficiency of mRNA vaccines has been motivated by the ongoing constraints of the present mRNA vaccine delivery systems. In this context, intriguing methods to get beyond these restrictions include lipid nanoparticles, self-amplifying RNA, electroporation, microneedles, and cell-targeted administration. These innovative methods could increase the effectiveness, safety, and use of mRNA vaccines, making them more efficient, effective, and broadly available. Additionally, mRNA technology may have numerous and far-reaching uses in the field of medicine, opening up fresh avenues for the diagnosis and treatment of disease. This paper gives an overview of the existing drawbacks of mRNA vaccine delivery techniques, the creative solutions created to address these drawbacks, and their prospective public health implications. The development of mRNA vaccines for illnesses other than infectious diseases and creating scalable and affordable manufacturing processes are some of the future directions for research in this area that are covered in this paper | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Electroporation | |
650 | 4 | |a Lipid nanoparticles | |
650 | 4 | |a Microneedles | |
650 | 4 | |a Self-amplifying RNA | |
650 | 4 | |a Vaccines | |
650 | 4 | |a mRNA | |
700 | 1 | |a Awasthi, Ankit |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current pharmaceutical design |d 1998 |g (2024) vom: 28. März |w (DE-627)NLM095430172 |x 1873-4286 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:28 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/0113816128296588240321072042 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 28 |c 03 |